AMLo Biosciences
Newcastle upon Tyne, United Kingdom
AMLo has developed a proprietary set of antibodies that can be applied to spare tissue biopsy sections and which accurately identifies patients at genuinely low risk of disease progression. AMBLor® fits easily into the existing histological analysis of specimens and provides the pathologist with highly relevant clinical information. Users of the AMBLor® tests will require no additional equipment and minimal training.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2017
- Website
- amlo-biosciences.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of AMLo Biosciences?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now